Done, Mental Health Startup Investigated by Drug Enforcement Administration

According to the news, the US Drug Enforcement Agency is investigating mental health startup Done for the administration of controlled substances.

Wall Street Magazine first reported the investigation.

Done and fellow mental health startup Cerebral are being investigated by the Subversives Division for their prescription of Adderall and other controlled substances, according to the report.

A spokesman for Done said the company “has not received any notice from the Drug Enforcement Administration, the Department of Justice, or any other federal agency regarding the investigation, request for records, or retention of documents.”

A spokesperson for Done said the company does not treat or diagnose people with ADHD, but provides “a platform that allows people to connect with qualified clinicians to both diagnose and treat ADHD patients.” The company said these doctors are not employees or contractors.

A spokesman for Cerebral said it would not comment on pending investigations, but added that the company is fully cooperating with any investigation. A DEA spokesman did not comment.

Download the Modern Healthcare app to keep up to date with industry news.

Cerebral has allegedly been linked to numerous federal government investigations. In June, The US Federal Trade Commission reportedly sent a letter to Cerebral. requesting information about whether the company continued to charge patients even after they tried to cancel their subscription. According to the report, the Federal Trade Commission asked Cerebral to keep the relevant documents.

Cerebral received a grand jury a subpoena from the U.S. Attorney’s Office for the Eastern District of New York in May regarding an investigation into “possible violations of the Controlled Substances Act” related to how it prescribed ADHD medications. It is not clear if this investigation is related to the investigation reported by the DEA.

In response to a grand jury subpoena in May, Cerebral said it had not been charged with violating any laws. On the same day, the company announced that no longer prescribing certain controlled substances for the treatment of ADHD. In late May, Walmart, CVS Health, and other national pharmacy chains said they were going to stop selling ADHD drugs from Cerebral and Done.

This story first appeared in Business and technology of digital health.